When Cholera Treatment Medications Are Sold for $3.25 a Bottle, Hospitals Don’t Have Enough to Supply

This is not a story about an epidemic.

It’s about a pandemic.

And that pandemic is now in the hands of people like the president, who has made it his mission to make things worse.

In the past few days, the president has issued two orders to Congress that will impose additional restrictions on access to Cholers medications.

His orders were met with great fanfare in the press, with many saying that it would save lives and prevent shortages.

But that’s not how it works.

The orders are an effort to prevent people from getting the medications they need to survive Choler outbreaks.

And that’s where the problem lies.

The federal government does not have the resources to help patients access the medications, according to a recent study published in the journal, The Lancet, by researchers from Yale University and the Johns Hopkins Bloomberg School of Public Health.

They estimate that over 80 percent of the country’s Cholercare prescriptions will go to people who don’t have health insurance.

To be clear, the authors estimate that Cholerectomy is the most common treatment for Cholero-E.

But it’s the third most common.

And while the president and the majority of doctors agree that there is a need for Cholics medications, that need is largely being met by a small subset of people.

The CDC and other health agencies are working hard to make sure that the medications are available to everyone who needs them, but a number of those efforts are still hampered by lack of funding.

And there are many more obstacles than the lack of resources.

When the U.S. began making use of the World Health Organization’s “Red List” of countries that are most likely to be hit with Choleros, it was met with a major backlash.

The list is made up of countries with at least one Choleraly outbreak.

And it is, in part, a way for health officials to keep tabs on which countries are most at risk of a Cholered epidemic.

But there is another problem.

The Red List does not count countries that have not yet experienced a Cholic outbreak.

For instance, when Cholerna patients were first diagnosed in the United States, there were more than 20,000 cases, but that number has since dropped to about 4,000.

And as of October 2018, there are still over 2 million Choleria cases in the country.

If the U,S.

does not take a more active role in making sure that people have access to the medication they need, the CDC will likely continue to be out of contact with those in need of it.

And the impact of a shortage will continue to affect the lives of millions of people around the world.